BACK
portfolio company

Prellis

sector
Drug Discovery & Therapeutics
 •
status
Active
Initial Investment
2021
location
USA
3D printing of synthetic human tissues to advance drug discovery and development.
company overview

Prellis Biologics uses high-resolution holographic laser printing to fabricate human lymph node organoids and other synthetic tissues for accelerating drug discovery, vaccine development, and antibody therapeutics.

social media
Related NEWS